|
|
|
|
|
||
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 108, Issue 8 2825-2838, Copyright © 1995 by Company of Biologists
JOURNAL ARTICLES |
F Mitjans, D Sander, J Adan, A Sutter, JM Martinez, CS Jaggle, JM Moyano, HG Kreysch, J Piulats and SL Goodman
Merck Farma y Quimica, Laboratorio de Bioinvestigacion (LBI), Barcelona, Spain.
A series of murine monoclonal antibodies were raised against purified human alpha v beta 3 integrin and against M21 human melanoma cells. Five notable hybridomas were identified by ELISA on purified integrins, and the isolated antibodies bound the alpha v-chain. These antibodies, 17E6, 20A9, 23G5, 14D9.F8 and 10G2, recognised the extracellular domains of the integrin, and were shown to be reactive in FACS, immunoprecipitation, ELISA, and ELISA on fixed cells with M21, M21-L4, and UCLA-P3, but not with the alpha v-deficient M21-L or M21-L-IIb (M21-L transfected with GpIIb integrin). One antibody, 17E6, strongly perturbed cell attachment mediated by alpha v integrins, reacting at least with alpha v beta 3, alpha v beta 5, and alpha v beta 1, and strongly inhibiting cell attachment to alpha v-ligands vitronectin and fibronectin with an IC50 of approximately 0.1 microgram ml-1. Furthermore, 17E6 at this concentration could induce cell retraction from the substrate, while LM609 (anti-alpha v beta 3) and control antibody 14E2 (anti-200 kDa melanoma surface protein) at 1,000-fold higher concentrations had minimal effects on cell morphology. The action of 17E6 was reversible and was not due to toxic effects: in vitro 17E6 at 0.1 mg ml-1 did not affect either cell proliferation or DNA synthesis. In two nude-mouse tumour models, subcutaneous tumour development and a lung colonisation ('experimental metastasis') assay, injection of 17E6 strongly inhibited tumour development, while isotype-matched controls had no effect. There was no obvious mechanism of cell or of complement-mediated tumour cytotoxicity; the antibody did not mediate ADCC or AECDC, or complement fixation. The data strongly support previous studies which have indicated the importance of alpha v-integrins, and especially alpha v beta 3, in the tumour progression of human melanoma.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  J.-P. Xiong, B. Mahalingham, J. L. Alonso, L. A. Borrelli, X. Rui, S. Anand, B. T. Hyman, T. Rysiok, D. Muller-Pompalla, S. L. Goodman, et al. Crystal structure of the complete integrin {alpha}V{beta}3 ectodomain plus an {alpha}/{beta} transmembrane fragment J. Cell Biol., August 24, 2009; 186(4): 589 - 600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Monnier, P. Farmer, G. Bieler, N. Imaizumi, T. Sengstag, G. C. Alghisi, J.-C. Stehle, L. Ciarloni, S. Andrejevic-Blant, R. Moeckli, et al. CYR61 and {alpha}V{beta}5 Integrin Cooperate to Promote Invasion and Metastasis of Tumors Growing in Preirradiated Stroma Cancer Res., September 15, 2008; 68(18): 7323 - 7331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kinsey, M. R. Williamson, S. Chaudhry, K. T. Mellody, A. McGovern, S. Takahashi, C. A. Shuttleworth, and C. M. Kielty Fibrillin-1 microfibril deposition is dependent on fibronectin assembly J. Cell Sci., August 15, 2008; 121(16): 2696 - 2704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Roth, M. Caunt, A. Cretu, A. Akalu, D. Policarpio, X. Li, P. Gagne, S. Formenti, and P. C. Brooks Inhibition of Experimental Metastasis by Targeting the HUIV26 Cryptic Epitope in Collagen Am. J. Pathol., May 1, 2006; 168(5): 1576 - 1586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. McNeel, J. Eickhoff, F. T. Lee, D. M. King, D. Alberti, J. P. Thomas, A. Friedl, J. Kolesar, R. Marnocha, J. Volkman, et al. Phase I Trial of a Monoclonal Antibody Specific for {alpha}v{beta}3 Integrin (MEDI-522) in Patients with Advanced Malignancies, Including an Assessment of Effect on Tumor Perfusion Clin. Cancer Res., November 1, 2005; 11(21): 7851 - 7860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Nisato, G. Hosseini, C. Sirrenberg, G. S. Butler, T. Crabbe, A. J.P. Docherty, M. Wiesner, G. Murphy, C. M. Overall, S. L. Goodman, et al. Dissecting the Role of Matrix Metalloproteinases (MMP) and Integrin {alpha}v{beta}3 in Angiogenesis In vitro: Absence of Hemopexin C Domain Bioactivity, but Membrane-Type 1-MMP and {alpha}v{beta}3 Are Critical Cancer Res., October 15, 2005; 65(20): 9377 - 9387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ebrahimnejad, T. Streichert, P. Nollau, A. K. Horst, C. Wagener, A.-M. Bamberger, and J. Brummer CEACAM1 Enhances Invasion and Migration of Melanocytic and Melanoma Cells Am. J. Pathol., November 1, 2004; 165(5): 1781 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Cominetti, C. H. B. Terruggi, O. H. P. Ramos, J. W. Fox, A. Mariano-Oliveira, M. S. De Freitas, C. C. Figueiredo, V. Morandi, and H. S. Selistre-de-Araujo Alternagin-C, a Disintegrin-like Protein, Induces Vascular Endothelial Cell Growth Factor (VEGF) Expression and Endothelial Cell Proliferation in Vitro J. Biol. Chem., April 30, 2004; 279(18): 18247 - 18255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Imelli, O. Meier, K. Boucke, S. Hemmi, and U. F. Greber Cholesterol Is Required for Endocytosis and Endosomal Escape of Adenovirus Type 2 J. Virol., March 15, 2004; 78(6): 3089 - 3098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Burke, S. J. DeNardo, L. A. Miers, K. R. Lamborn, S. Matzku, and G. L. DeNardo Cilengitide Targeting of {alpha}v{beta}3 Integrin Receptor Synergizes with Radioimmunotherapy to Increase Efficacy and Apoptosis in Breast Cancer Xenografts Cancer Res., August 1, 2002; 62(15): 4263 - 4272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Sturm, K. Satyamoorthy, F. Meier, B. B. Gardiner, D. J. Smit, B. Vaidya, and M. Herlyn Osteonectin/SPARC Induction by Ectopic {beta}3 Integrin in Human Radial Growth Phase Primary Melanoma Cells Cancer Res., January 1, 2002; 62(1): 226 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M von Schlippe, J. Marshall, P Perry, M Stone, A. Zhu, and I. Hart Functional interaction between E-cadherin and alphav-containing integrins in carcinoma cells J. Cell Sci., January 2, 2000; 113(3): 425 - 437. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Maaser, K. Wolf, C. E. Klein, B. Niggemann, K. S. Zänker, E.-B. Bröcker, and P. Friedl Functional Hierarchy of Simultaneously Expressed Adhesion Receptors: Integrin alpha 2beta 1 but Not CD44 Mediates MV3 Melanoma Cell Migration and Matrix Reorganization within Three-dimensional Hyaluronan-containing Collagen Matrices Mol. Biol. Cell, October 1, 1999; 10(10): 3067 - 3079. [Abstract] [Full Text]
|
|
|
|
|
|
E. Petitclerc, S. Stromblad, T. L. von Schalscha, F. Mitjans, J. Piulats, A. M. P. Montgomery, D. A. Cheresh, and P. C. Brooks Integrin {{alpha}}V{beta}3 Promotes M21 Melanoma Growth in Human Skin by Regulating Tumor Cell Survival Cancer Res., June 1, 1999; 59(11): 2724 - 2730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kraft, B. Diefenbach, R. Mehta, A. Jonczyk, G. A. Luckenbach, and S. L. Goodman Definition of an Unexpected Ligand Recognition Motif for alpha vbeta 6 Integrin J. Biol. Chem., January 22, 1999; 274(4): 1979 - 1985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-Y. Hsu, D.-T. Shih, F. E. Meier, P. Van Belle, J.-Y. Hsu, D. E. Elder, C. A. Buck, and M. Herlyn Adenoviral Gene Transfer of ß3 Integrin Subunit Induces Conversion from Radial to Vertical Growth Phase in Primary Human Melanoma Am. J. Pathol., November 1, 1998; 153(5): 1435 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Felding-Habermann, S. Silletti, F. Mei, C.-H. Siu, P. M. Yip, P. C. Brooks, D. A. Cheresh, T. E. O'Toole, M. H. Ginsberg, and A. M.P. Montgomery A Single Immunoglobulin-like Domain of the Human Neural Cell Adhesion Molecule L1 Supports Adhesion by Multiple Vascular and Platelet Integrins J. Cell Biol., December 15, 1997; 139(6): 1567 - 1581. [Abstract] [Full Text] [PDF]
|
|
